Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia.
作者信息
Bou Khalil Rami
机构信息
Department of psychiatry, Hotel Dieu de France- Beirut- Lebanon, Saint Joseph University, Beirut, Lebanon.
出版信息
Med Hypotheses. 2020 Sep;142:109798. doi: 10.1016/j.mehy.2020.109798. Epub 2020 May 1.
Abstract
摘要
相似文献
1
Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia.氯化锂与雷帕霉素联合用于治疗新冠肺炎肺炎。
Med Hypotheses. 2020 Sep;142:109798. doi: 10.1016/j.mehy.2020.109798. Epub 2020 May 1.
2
Statin therapy and SAR-COV-2: an available and potential therapy?他汀类药物治疗与新型冠状病毒2：一种可行且有潜力的治疗方法？
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):333-334. doi: 10.1093/ehjcvp/pvaa050.
3
[Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].[严重急性呼吸综合征冠状病毒2（SARS-CoV-2）：我们应该针对病毒、细胞还是疾病？]
Virologie (Montrouge). 2020 Jun 1;24(3):135-141. doi: 10.1684/vir.2020.0843.
4
Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?多发性硬化症中干扰素-β的三十年：我们能否将这些信息用于治疗新型冠状病毒2感染？
Front Immunol. 2020 Jun 18;11:1459. doi: 10.3389/fimmu.2020.01459. eCollection 2020.
5
Audio Interview: Tocilizumab and Covid-19.音频访谈：托珠单抗与新冠病毒
N Engl J Med. 2020 Oct 22;383(17):e114. doi: 10.1056/NEJMe2032051.
6
Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19.雷帕霉素作为一种治疗 COVID-19 的潜在再利用药物候选物。
Chem Biol Interact. 2020 Nov 1;331:109282. doi: 10.1016/j.cbi.2020.109282. Epub 2020 Oct 6.
7
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19.伊维菌素可能是一种对晚期新冠肺炎有临床实用价值的抗炎药。
Open Heart. 2020 Sep;7(2). doi: 10.1136/openhrt-2020-001350.
8
A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.全面更新的关于 SARS-CoV-2 和 COVID-19 的综述。
J Clin Pharmacol. 2020 Aug;60(8):954-975. doi: 10.1002/jcph.1673. Epub 2020 Jun 24.
9
Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.用雷帕霉素靶向T细胞衰老和细胞因子风暴以预防COVID-19的严重进展。
Clin Immunol. 2020 Jul;216:108464. doi: 10.1016/j.clim.2020.108464. Epub 2020 May 13.
10
Hydroxychloroquine in Covid-19: Does the end justify the means?新冠疫情中使用羟氯喹：结果能证明手段合理吗？
Curr Res Transl Med. 2020 Aug;68(3):81-82. doi: 10.1016/j.retram.2020.04.002. Epub 2020 Apr 18.
引用本文的文献
1
Molecular mechanisms and therapeutic effects of different vitamins and minerals in COVID-19 patients.不同维生素和矿物质在 COVID-19 患者中的分子机制和治疗效果。
J Trace Elem Med Biol. 2022 Sep;73:127044. doi: 10.1016/j.jtemb.2022.127044. Epub 2022 Jul 20.
2
Rapamycin golden jubilee and still the miraculous drug: a potent immunosuppressant, antitumor, rejuvenative agent, and potential contributor in COVID-19 treatment.雷帕霉素五十周年纪念，仍是神奇药物：一种强效免疫抑制剂、抗肿瘤药、回春剂，以及COVID-19治疗中的潜在贡献者。
Bioresour Bioprocess. 2022;9(1):65. doi: 10.1186/s40643-022-00554-y. Epub 2022 Jun 13.
3
Psychotropics and COVID-19: An analysis of safety and prophylaxis.精神药物与 COVID-19：安全性与预防分析。
Encephale. 2021 Dec;47(6):564-588. doi: 10.1016/j.encep.2021.08.002. Epub 2021 Sep 2.
4
Towards a pharmacochemical hypothesis of the prophylaxis of SARS-CoV-2 by psychoactive substances.从精神活性物质预防 SARS-CoV-2 的药理学假说角度探讨。
Med Hypotheses. 2020 Nov;144:110025. doi: 10.1016/j.mehy.2020.110025. Epub 2020 Jun 23.
5
Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.糖原合酶激酶-3：一种潜在的靶点，可用于对抗严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）大流行。
Cytokine Growth Factor Rev. 2021 Apr;58:92-101. doi: 10.1016/j.cytogfr.2020.08.002. Epub 2020 Aug 25.
本文引用的文献
1
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病（COVID-19）患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.
2
mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3.mTOR 抑制剂降低了 IFITM3 介导的病毒感染的内在屏障。
Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10069-E10078. doi: 10.1073/pnas.1811892115. Epub 2018 Oct 9.
3
Antiviral effect of lithium chloride on porcine epidemic diarrhea virus in vitro.氯化锂对猪流行性腹泻病毒的体外抗病毒作用
Res Vet Sci. 2018 Jun;118:288-294. doi: 10.1016/j.rvsc.2018.03.002. Epub 2018 Mar 5.
4
An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.老药新用：通过神经保护和神经营养机制治疗双相情感障碍的锂。
Int J Mol Sci. 2017 Dec 11;18(12):2679. doi: 10.3390/ijms18122679.
5
Autophagy Negatively Regulates Transmissible Gastroenteritis Virus Replication.自噬负调控传染性胃肠炎病毒复制。
Sci Rep. 2016 Mar 31;6:23864. doi: 10.1038/srep23864.
6
Antibiotics produced by Streptomyces.链霉菌产生的抗生素。
Braz J Infect Dis. 2012 Sep-Oct;16(5):466-71. doi: 10.1016/j.bjid.2012.08.014. Epub 2012 Sep 11.
7
Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-β-signaling pathways regulates the innate inflammatory response.哺乳动物雷帕霉素靶蛋白复合物 1 和糖原合成酶激酶 3-β 信号通路的会聚调节固有炎症反应。
J Immunol. 2011 May 1;186(9):5217-26. doi: 10.4049/jimmunol.1002513. Epub 2011 Mar 21.
8
Biosynthesis of rapamycin and its regulation: past achievements and recent progress.雷帕霉素的生物合成及其调控：过去的成就和最近的进展。
J Antibiot (Tokyo). 2010 Aug;63(8):434-41. doi: 10.1038/ja.2010.71. Epub 2010 Jun 30.
9
Comparative analysis of the effect of glycyrrhizin diammonium and lithium chloride on infectious bronchitis virus infection in vitro.甘草酸二铵与氯化锂对体外传染性支气管炎病毒感染影响的比较分析
Avian Pathol. 2009 Jun;38(3):215-21. doi: 10.1080/03079450902912184.
10
Lithium chloride inhibits the coronavirus infectious bronchitis virus in cell culture.氯化锂在细胞培养中可抑制冠状病毒性传染性支气管炎病毒。
Avian Pathol. 2007 Apr;36(2):109-14. doi: 10.1080/03079450601156083.
Zotero 插件